Inne informacje
Q3 2026 · 3 września 2026
The company disclosed its August 2026 sales figures, highlighting modest growth for the parent company (PLN 4.9M, +0.42% LfL YoY) and stronger performance at its subsidiary Eko-Wital (PLN 6.5M, +11% YoY). Group sales totaled PLN 9.7M, reflecting a 6% LfL increase YoY. For the first eight months, parent sales amounted to PLN 48M (+7% LfL YoY), subsidiary sales to PLN 60M (+15.3% YoY), and group sales to PLN 92M (+12% LfL YoY). The data indicate steady top‑line expansion, though the magnitude of growth is moderate. No earnings, guidance, or corporate actions were announced, making the release primarily informational.
Kluczowe dane finansowe
-
PLN 4.9MAugust 2026 Parent Sales
Sales of Organic Farma Zdrowia S.A. in August 2026, up 0.42% LfL YoY.
-
PLN 6.5MAugust 2026 Subsidiary Sales
Sales of Eko-Wital Sp. z o.o. in August 2026, up 11% YoY.
-
PLN 9.7MAugust 2026 Group Sales
Total group sales in August 2026, up 6% LfL YoY.
-
PLN 48MYTD Jan‑Aug 2026 Parent Sales
Parent sales for the first eight months of 2026, up 7% LfL YoY.
-
PLN 60MYTD Jan‑Aug 2026 Subsidiary Sales
Subsidiary sales for Jan‑Aug 2026, up 15.3% YoY.
-
PLN 92MYTD Jan‑Aug 2026 Group Sales
Group sales for Jan‑Aug 2026, up 12% LfL YoY.
-
18/2026Report Number
Identifier of the current regulatory filing.
-
2026-09-03Publication Date
Date the report was disseminated to the market.
Najważniejsze wnioski
Sprzedaż ORG w sierpniu 2026 wzrosła 6% LfL — stabilny rozwój grupy